Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer-Reference-Cited by-同舟云学术

Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer

Published:2020-10-06 Issue:3 Volume:2 Page:169-177
ISSN:2688-4526
Container-title:BJUI Compass
language:en
Short-container-title:BJUI Compass

Author:

Sato Shun¹^ORCID,Kimura Takahiro²,Onuma Hajime²,Egawa Shin²,Takahashi Hiroyuki¹

Affiliation:

1. Department of Pathology the Jikei University School of Medicine Tokyo Japan

2. Department of Urology the Jikei University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Religious studies,Cultural Studies

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bco2.47

Reference33 articles.

1. BrayF ColombetM MeryL PiñerosM ZnaorA ZanettiR et al. Cancer incidence in five continents Vol. XI (electronic version). Lyon: International Agency for Research on Cancer;2017[cited 2020 May 01] Available from:https://ci5.iarc.fr

2. Further Evidence of Differences in Prostate Cancer Biomarkers Between Caucasian and Asian Men

3. Regional Morphology and Pathology of The Prostate

4. Normal Histology of the Prostate

5. Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of zonal origin in clinically localized prostate cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-12-08

2. Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer;Diagnostic and Interventional Radiology;2023-11-01

3. Characteristics of incidental prostate cancer in the United States;Prostate Cancer and Prostatic Diseases;2023-10-23

4. Prostate‐specific antigen follow‐up and management for patients undergoing holmium laser enucleation of the prostate;International Journal of Urology;2023-10-06

5. Characteristics of incidental prostate cancer in the United States;2023-08-09